Accredited Investors’s ReposiTrak TRAK Stock Holding History

Accredited Investors’s Portfolio TRAK Stock Details TRAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,850	Closed	-$104K	–	125
2017 Q4	$104K	Buy	+10,850	New	+$119K	0.03%	113

Other funds holding TRAK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $774M AUM 40.73% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $1.07B AUM 34.04% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Accredited Investors's TRAK Position: Q1 2018 in Review

Accredited Investors sold out of ReposiTrak (TRAK) in Q1 2018, closing a stake of 10,850 shares — an estimated $104K sold.

Accredited Investors first reported a position in TRAK in Q4 2017 and held it in 1 quarter. The position peaked at $104K in Q4 2017. 54 funds tracked by Wall St. Rank hold TRAK as of Q1 2018.

Accredited Investors reported no remaining ReposiTrak position as of Q1 2018 after selling out during the quarter.
Accredited Investors sold 10,850 ReposiTrak shares in Q1 2018, an estimated $104K.
Accredited Investors first reported a position in ReposiTrak in Q4 2017 and held it in 1 quarter.
Accredited Investors's ReposiTrak position peaked at $104K in Q4 2017.
54 funds tracked by Wall St. Rank held ReposiTrak as of Q1 2018.

Based on Accredited Investors's 13F filing for Q1 2018, filed 18 Apr 2018.